|Bid||2,320.00 x 400000|
|Ask||2,454.99 x 400000|
|Day's Range||2,345.50 - 2,384.08|
|52 Week Range||2,104.50 - 2,574.00|
|PE Ratio (TTM)||394.49|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Majority Leader Mitch McConnell needed 50 out of the 52 Senate Republicans to support him.
Income investors who are living off the money their portfolios generate don't just want consistency -- they want steady payout growth. Lowe's, Johnson & Johnson, and Altria offer both.
JACKSON, Miss., July 25, 2017 /PRNewswire/ -- As the number of lawsuits against the blood thinner Xarelto continues to climb, so do reports of injuries and deaths caused by the controversial anticoagulant, according to a recent study by the Institute for Safe Medication Practices (ISMP). According to ISMP, the U.S. Food and Drug Administration received 15,043 reports of serious injury or death linked to Xarelto last year — a 41 percent increase over the previous year.